Skip to content
Finance Investment

Quiet Achiever announces record return of 37% for International Equities to 30 June 2023.

www.ppmfunds.com 2 mins read

Sydney, Australia 09.00am 25 August, 2023Private Portfolio Managers (PPM FUNDS) has announced a record 37% return on its International Equities to 30 June 2023  averaging 22% over the past 3 years and cites its 28 year experience riding out multiple cycles of market volatility as a key reason for their consistent performance track record. 

  

PPM is one of Australia's highest performing boutique fund managers, and has also secured a 12.8% return in 2023 on its domestic fund and 13.1% over the same three-year period.   

  

"Our clients are wealthy private individuals or families who are referred by friends or their trusted financial adviser.  It's a tight and close-knit communication loop where privacy is paramount.  It makes it challenging to communicate our performance record, but results like these give us an opportunity to showcase our consistently outstanding results," said Founder, Chief Investment Officer and Chairman of PPM, Hugh MacNally. 

  

“Our service offering to Financial Advisers is significant.  The Financial Adviser is the custodian of the client relationship – and we relieve the burden of funds management and partner with them to achieve results for their clients,” says MacNally. 

  

"I started PPM when I was relatively young - and the profile of previously thought of “typical investors” has changed. I am now the father of three school age children with one still in primary school, and today, investors want consistency of management and not delegation to a junior team.  

 

“Our investors, whether financially literate or seeking guidance, want to have the ability to communicate directly with the manager of their assets and understand how their portfolio is managed.   

 

“Each has different taxation situations that are best addressed by having their investment management integrated with their tax advisor’s strategy. It takes experience and hands on intervention to tend to these individual client profiles whether a Family Office, Financial Adviser, or individuals. 

  

"One of our key differences in contrast to many of our peers is that our investors can pick up the phone and talk directly to the person that is managing their funds." 

  

PPM’s investment management team is an experienced group of analysts who conduct proprietary research on companies globally.   

Ends.


About us:

For further information or to discuss partnering with PPM, contact:  Hugh MacNally (02) 8256 3702 or 0414 728 638 or Jill May (02) 8256 3712 or 0412 033 359

 


Contact details:

0435 123 350 Samantha Herron PR Manager 

or contact Hugh MacNally direct:  0414 728 639 or (02) 8256 3702 or (02) 8256 3777

More from this category

  • Finance Investment
  • 16/03/2026
  • 23:40
SEALMINER

Bitdeer Launches SEALMINER DL1 Air: Achieving 149 J/GH Power Efficiency and 25 GH/s for Scrypt Mining

SINGAPORE, March 16, 2026 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for AI and Bitcoin mining infrastructure, today announced the launch of its latest self-developed mining machine, the SEALMINER DL1 Air. Optimized for the Scrypt algorithm, the DL1 Air provides a robust, industrial-grade solution for professional operators, supporting a range of coins headlined by Litecoin (LTC) and Dogecoin (DOGE).By leveraging Bitdeer’s proprietary ASIC technology, the DL1 Air focuses on long-term operational stability and advanced power management to meet the growing demand for high-efficiency mining hardware.Key Specifications of the SEALMINER DL1 Air*:Hash…

  • Biotechnology, Finance Investment
  • 16/03/2026
  • 14:38
Jane Morgan Management

BlinkLab Limited (ASX:BB1) Completes Clinical Trial Network for Pivotal FDA Study with Tenth U.S. Site Onboarded

16 March 2026 – Perth, Australia | BlinkLab Limited (ASX:BB1) has completed the clinical site network for its pivotal U.S. FDA 510(k) study of BlinkLab Dx 1, with the University of Arkansas joining as the tenth and final participating site. The milestone completes the onboarding of all clinical centres for the Company’s pivotal study of its smartphone-based diagnostic aid for autism, positioning BlinkLab to begin first patient testing later this month and commence the main study phase in the first quarter of 2026. The FDA-endorsed pivotal trial is designed to validate both the usability and diagnostic accuracy of BlinkLab Dx…

  • Contains:
  • Finance Investment
  • 16/03/2026
  • 13:00
First Super

First Super appoints Greg Everett as Acting CEO

First Super is pleased to announce the appointment of Greg Everett as Acting CEO, effective 16 March 2026. Greg steps into the acting role following Bill Watson’s resignation in early January. First Super’s Co-Chairs, Mike Radda and Denise Campbell-Burns, said Greg was well-placed to drive First’s strategy and maintain member focus. “Greg and the executive will maintain momentum, deliver our strategy and support operations through this transition period,” Mike Radda said. Greg joined First Super as Deputy CEO in November, bringing with him more than 20 years of superannuation experience, including CEO of the Superannuation Trustee Office for Guild Group,…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.